Table 4: Comparison of FSF between POC users.

Mean ± SD

DMPA (n = 88)

Etonogestrel implant (n = 87)

Desogestrel pills (n = 47)

P-Value

Desire

3.18 ± 1.27

4.48 ± 0.62

4.88 ± 0.63

0.000*

(95% CI)

(2.91 ± 3.45)

(4.35 ± 4.61)

(4.69 ± 5.06)

 

Arousal

4.51 ± 0.68

4.40 ± 0.65

4.37 ± 0.73

0.390

(95% CI)

(4.37 ± 4.66)

(4.26 ± 4.54)

(4.15 ± 4.58)

 

Lubrication

3.62 ± 0.80

4.62 ± 0.72

4.65 ± 0.73

0.009*

(95% CI)

(3.45 ± 3.70)

(4.47 ± 4.77)

(4.43 ± 4.86)

 

Orgasm

4.49 ± 0.79

4.69 ± 0.72

4.60 ± 0.84

0.249

(95% CI)

(4.33 ± 4.66)

(4.54 ± 4.84)

(4.35 ± 4.84)

 

Satisfaction

4.50 ± 0.87

4.47 ± 0.70

4.42 ± 0.80

0.313

(95% CI)

(4.45 ± 4.70)

(4.32 ± 4.62)

(4.18 ± 4.65)

 

Pain

4.51 ± 0.80

4.47 ± 0.77

4.47 ± 0.78

0.327

(95% CI)

(4.40 ± 4.98)

(4.30 ± 4.63)

(4.24 ± 4.70)

 

Total ArFSFI score

25.46 ± 1.75

26.13 ± 1.89

26.37 ± 1.93

0.010*

(95% CI)

(25.09 ± 25.83)

(25.73 ± 26.53)

(25.80 ± 26.94)

 

No. of women with FSD#

68 (77.2%)

44 (50.5%)

16 (34.0%)

0.000*

ArFSFI: Arabic Female Sexual Function Index; CI: Confidence Interval; FSF: Female Sexual Function; POC: Progesterone Only Contraception; SD: Standard Deviation; #Variable presented by number and percentage; *Statistical significance if p-value < 0.05.